Radioactive Iodine Shows No Benefit in Low-Risk Thyroid Cancer
A prospective, randomized trial provides further evidence that use of radioiodine ablation after surgery for low-risk differentiated thyroid cancer does not result in any benefit.
Johns Hopkins University United States France General Basse Normandie Davids Cooper Sophie Leboulleux
Source: medscape.com